GUARD
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Guard Therapeutics is engaged in the development of drugs in the field of oxidative stress. The company focuses primarily on research, development and commercialization of drugs that aim to prevent the onset and complications of acute kidney injury. The drug has been shown in preclinical studies to protect exposed tissue and support regenerative processes. The company is headquartered in Lund.
Lue lisääEPS (oik.)
Osinko %
Ylimääräinen yhtiökokous '26
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.